吉林大学学报(医学版) ›› 2022, Vol. 48 ›› Issue (4): 995-1002.doi: 10.13481/j.1671-587X.20220420

• 临床研究 • 上一篇    下一篇

甲状腺乳头状癌患者临床病理特征和BRAF V600E基因突变对其颈部淋巴结转移的影响

姬巍1,董健2(),昌红3,杜雪梅3,彭洪1,谢洪1,赵爱民4,闫巍5,白娟1,彭振兴1,尹金淑1   

  1. 1.首都医科大学附属北京世纪坛医院耳鼻喉科,北京 100038
    2.首都医科大学附属北京世纪坛医院放射科,北京 100038
    3.首都医科大学附属北京世纪坛医院病理科,北京 100038
    4.首都医科大学附属北京世纪坛医院结直肠外科,北京 100038
    5.首都医科大学 附属北京世纪坛医院肝胆外科,北京 100038
  • 收稿日期:2021-12-07 出版日期:2022-07-28 发布日期:2022-07-26
  • 通讯作者: 董健 E-mail:dongjian3070@bjsjth.cn
  • 作者简介:姬 巍(1976-),男,山东省汶上县人,主治医师,医学硕士,主要从事耳鼻喉头颈外科方面的研究。
  • 基金资助:
    北京市科学技术委员会首都临床特色应用研究与成果推广项目(Z161100000516)

Influence of chinicopathological characteristics and BRAF V600E gene mutation in cervical lymph node metastasis in patients with papillary thyroid cancer

Wei JI1,Jian DONG2(),Hong CHANG3,Xuemei DU3,Hong PENG1,Hong XIE1,Aimin ZHAO4,Wei YAN5,Juan BAI1,Zhenxing PENG1,Jinshu YIN1   

  1. 1.Department of Otolaryngology,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China
    2.Department of Radiology,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China
    3.Department of Pathology,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China
    4.Department of Colorectal Surgery,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China
    5.Department of Hepatobiliary Surgery,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China
  • Received:2021-12-07 Online:2022-07-28 Published:2022-07-26
  • Contact: Jian DONG E-mail:dongjian3070@bjsjth.cn

摘要: 目的

探讨甲状腺乳头状癌(PTC)患者颈部淋巴结转移与原发灶临床病理特征和BRAFV600E基因突变的关联性,阐明PTC患者颈部淋巴结转移的影响因素。

方法

选择因PTC在本院手术治疗的患者,回顾性分析其临床资料,包括患者年龄,性别,原发灶部位和数量,淋巴结转移数量和位置;病理学资料,包括肿瘤的位置、大小、数目和包膜侵犯,瘤周纤维包裹,检出砂粒体,脉管和神经受累。检测PTC组织中BRAF V600E基因突变情况,分析颈部淋巴结转移与PTC患者临床特征、病理学特点和BRAF V600E基因突变的关联性,采用多因素Logistic回归模型分析PTC患者颈部淋巴结转移的影响因素。

结果

共选择PTC患者321例,其中发生颈部淋巴结转移者129例(40.2%)。279例(86.9%)患者伴有BRAF V600E基因突变,但BRAF V600E基因突变与PTC淋巴结转移无关联(P>0.05)。PTC患者颈部淋巴结转移与患者发病年龄、肿瘤最大径、甲状腺双侧叶多原发灶、检出砂粒体和脉管受侵有关联(P<0.05或P<0.01)。多因素Logistic回归分析,PTC患者年龄(OR=0.729,95%CI:0.600~0.885)、肿瘤最大径(OR=1.796,95%CI:1.326~2.433)、原发灶数量(OR=1.947,95%CI:1.225~3.096)、检出砂粒体(OR=2.578,95%CI:1.037~6.409)和脉管受侵(OR=8.856,95%CI:1.929~40.656)是PTC患者淋巴结转移的影响因素。

结论

PTC患者发生颈部淋巴结转移与患者年龄、肿瘤最大径、原发灶数量、检出砂粒体和脉管受侵有关联,与BRAF V600E基因突变无关联。

关键词: 甲状腺乳头状癌, BRAFV600E基因, 淋巴结, 转移

Abstract:

Objective: To investigate the correlations of cervical lymph node metastasis with the chinicopathological characteristics and BRAF V600E gene mutation in the patients with papillary thyroid cancer (PTC), and to clarify the influencing factors of cervical lymph nodes metastasis in the patients with PTC.

Methods

The PTC patients underwent surgical therapy in our hospital were selected;the patients’ clinical data were retrospectively analyzed, including age, sex, side, number, metastatic lymph nodes and location of the PTC patients, and the pathologic data were also analyzed, including location, diameter, number, capsular invasion, peri-tumor fibrosis, psammoma bodies, vascular and nervous invasion. The BRAF V600E mutation detection was performed in PTC tissue, the correlation of cervical lymph node metastasis with the clinical characteristics,pothological feateres and BRAF V600E gene mutation of the PTC patients were analyzed,and Logistic regression analysis was performed to analyze the influencing factors of cervical lymph node metastasis in the PTC patients.

Results

In the 321 PTC patients, 129 patients (40.2%) were found with cervical lymph node metastatasis. BRAF V600E gene mutation were found in 279 (86.9%) patients; there was no correlation of BRAF V600E gene mutation with cervical lymph node metastasis in the PTC patients(P>0.05).Cervical lymph node metastasis had correlations with age, maximal diameter, multiple tumors in bilateral sides, psammoma bodies and vascular invasion(P<0.05 or P<0.01). The results of Logistic regression analysis demonstrated that age (OR=0.729,95%CI:0.600-0.885), maximal tumor diameter (OR=1.796,95%CI:1.326-2.433), tumor number(OR=1.947,95%CI:1.225-3.096),psammoma bodies (OR=2.578,95%CI:1.037-6.409), and vascular invasions (OR=8.856,95%CI:1.929-40.656) were the influencing factors of cervical lymph node metastasis in the PTC patients.

Conclusion

The cervical lymph node metastasis of the PTC patients shows the correlations with age, maximal tumor diameter, tumor number, psammoma bodies and vascular invasion, and shows no correlation with BRAF V600E gene mutation.

Key words: Papillary thyroid cancer, BRAF V600E, Lymph node, Metastasis

中图分类号: 

  • R736.1